Drug intelligence / Profile preview

liposomal bupivacaine

Development stage
Phase 4
Lead developer
Pacira BioSciences
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Local Infiltration, Perineural
01

Overview

Liposomal bupivacaine is a long-acting local anesthetic formulated using multivesicular liposomes (DepoFoam technology) to provide extended-release delivery of the active ingredient, bupivacaine. It is indicated for postsurgical analgesia via single-dose infiltration into the surgical site or as a nerve block. The encapsulation in liposomes allows for slow release of bupivacaine over up to 72 hours, providing prolonged pain relief and reducing the need for opioids after surgery. Bupivacaine works by blocking sodium channels on nerve membranes, thereby inhibiting nerve impulse transmission and preventing pain signal propagation[1][3][5][6][8].

Brand names
Exparel
Other names
bupivacaine liposomebupivacaine liposomal injectionbupivacaine hydrochloride (liposomal formulation)
02

Targets

KCNQ1 (Potassium voltage-gated channel subfamily KQT member 1)PTGER1 (Prostaglandin E Receptor 1)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on liposomal bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liposomal bupivacaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call